{rfName}

Indexed in

License and use

Altmetrics

Grant support

The GPCRmd consortium acknowledges the support of COST Action CA18133, the European Research Network on Signal Transduction (https://ernest-gpcr.eu) and COST Action CM1207 GLISTEN. We thank R. Fonseca and A.J. Venkatakrishnan for their help implementing Flareplots into the GPCRmd toolkit. We also thank the volunteers of GPUGRID for donating their computing time for the simulations. M.T.-F. acknowledges financial support from the Spanish Ministry of Science, Innovation and Universities (FPU16/01209). T.M.S. acknowledges support from the National Center of Science, Poland (grant no. 2017/27/N/NZ2/02571). I.R.-E. acknowledges Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (2015 FI_B00145) for its financial support. X.D. and R.G.-G. acknowledge support from the Swiss National Science Foundation (grant no. 192780). P.K. thanks the German Research Foundation DFG for the Heisenberg professorship grant nos. KO4095/4-1 and KO4095/5-1 as well as project KO4095/3-1 (funding M.M.-S.). G.D.F. acknowledges support from MINECO (Unidad de Excelencia Maria de Maeztu, funded by the AEI (CEX2018-000782-M) and BIO2017-82628-P) and FEDER and from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 823712 (CompBioMed2 Project). D.L. acknowledges support from the National Centre of Science in Poland (DEC-2012/07/D/NZ1/04244). P.W.H. thanks the DFG (Hi 1502, project number 168703014; SFB1423, project number 421152132, subproject Z04), the Stiftung Charite and the Einstein Foundation. S.F. thanks the National Science Centre Poland grant no. 2017/25/B/NZ7/02788. M.F. acknowledges support by the Office of Research Infrastructure of the National Institutes of Health under award numbers S10OD018522 and S10OD026880, as well as the Extreme Science and Engineering Discovery Environment (XSEDE) under MCB080077, which is supported by National Science Foundation grant number ACI-1548562. J.K.S.T. acknowledges support from HPC-EUROPA3 (INFRAIA-2016-1-730897) and the EC Research Innovation Action under the H2020 Programme. The work was supported by grants from the Swedish Research Council (2017-4676), the Swedish strategic research program eSSENCE and the Science for Life Laboratory to J.C. H.W. and G.K. acknowledge support from NSF grant no. 1740990 for In Situ Data Analytics for Next Generation Molecular Dynamics Workflows, and the 1923 Fund. D.E.G. acknowledges the Lundbeck Foundation (R1632013-16327) and European Research Council (639125) for support. F.S. received support from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement number 802750 (FAIRplus) with the support of the European Union's Horizon 2020 Research and Innovation Programme and EFPIA Companies. The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), funded by ISCIII and FEDER (PT17/0009/0014). The DCEXS is a `Unidad de Excelencia Maria de Maeztu', funded by the AEI (CEX2018-000782-M). The GRIB is also supported by the Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya (2017 SGR 00519). Finally, J.S. acknowledges financial support from the Instituto de Salud Carlos III FEDER (PI15/00460 and PI18/00094) and the ERA-NET NEURON and Ministry of Economy, Industry and Competitiveness (AC18/00030).

Analysis of institutional authors

Rios, SantiagoAuthor

Share

July 1, 2022
Publications
>
Article
No

GPCRmd uncovers the dynamics of the 3D-GPCRome

Publicated to:Nature Methods. 17 (8): 777-787 - 2020-07-13 17(8), DOI: 10.1038/s41592-020-0884-y

Authors: Rodriguez-Espigares, Ismael; Torrens-Fontanals, Mariona; Tiemann, Johanna K S; Aranda-Garcia, David; Manuel Ramirez-Anguita, Juan; Stepniewski, Tomasz Maciej; Worp, Nathalie; Varela-Rial, Alejandro; Morales-Pastor, Adrian; Medel-Lacruz, Brian; Pandy-Szekeres, Gaspar; Mayol, Eduardo; Giorgino, Toni; Carlsson, Jens; Deupi, Xavier; Filipek, Slawomir; Filizola, Marta; Carlos Gomez-Tamayo, Jose; Gonzalez, Angel; Gutierrez-de-Teran, Hugo; Jimenez-Roses, Mireia; Jespers, Willem; Kapla, Jon; Khelashvili, George; Kolb, Peter; Latek, Dorota; Marti-Solano, Maria; Matricon, Pierre; Matsoukas, Minos-Timotheos; Miszta, Przemyslaw; Olivella, Mireia; Perez-Benito, Laura; Provasi, Davide; Rios, Santiago; Torrecillas, Ivan R; Sallander, Jessica; Sztyler, Agnieszka; Vasile, Silvana; Weinstein, Harel; Zachariae, Ulrich; Hildebrand, Peter W; De Fabritiis, Gianni; Sanz, Ferran; Gloriam, David E; Cordomi, Arnau; Guixa-Gonzalez, Ramon; Selent, Jana

Affiliations

Acellera, Barcelona, Spain - Author
Berlin Inst Hlth, Berlin, Germany - Author
Charite Univ Med Berlin, Inst Med Phys & Biophys, Berlin, Germany - Author
Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA - Author
Cornell Univ, Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA - Author
Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA - Author
Med Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Sachsen, Germany - Author
MRC Lab Mol Biol, Cambridge, England - Author
Natl Res Council Italy, Biophys Inst, Milan, Italy - Author
Paul Scherrer Inst PSI, Lab Biomol Res, Villigen, Switzerland - Author
Philipps Univ Marburg, Dept Pharmaceut Chem, Marburg, Germany - Author
Pompeu Fabra Univ, Dept Expt & Hlth Sci, Hosp Mar Med Res Inst, Res Programme Biomed Informat, Barcelona, Spain - Author
PSI, Condensed Matter Theory Grp, Villigen, Switzerland - Author
Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra, Spain - Author
Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark - Author
Univ Dundee, Sch Life Sci, Computat Biol, Dundee, Scotland - Author
Univ Dundee, Sch Sci & Engn, Phys, Dundee, Scotland - Author
Univ Milan, Dept Biosci, Milan, Italy - Author
Univ Patras, Dept Pharm, Patras, Greece - Author
Univ Pompeu Fabra, Computat Sci Lab, Barcelona Biomed Res Pk, Barcelona, Spain - Author
Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland - Author
Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden - Author
Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden - Author
See more

Abstract

G-protein-coupled receptors (GPCRs) are involved in numerous physiological processes and are the most frequent targets of approved drugs. The explosion in the number of new three-dimensional (3D) molecular structures of GPCRs (3D-GPCRome) over the last decade has greatly advanced the mechanistic understanding and drug design opportunities for this protein family. Molecular dynamics (MD) simulations have become a widely established technique for exploring the conformational landscape of proteins at an atomic level. However, the analysis and visualization of MD simulations require efficient storage resources and specialized software. Here we present GPCRmd (http://gpcrmd.org/), an online platform that incorporates web-based visualization capabilities as well as a comprehensive and user-friendly analysis toolbox that allows scientists from different disciplines to visualize, analyze and share GPCR MD data. GPCRmd originates from a community-driven effort to create an open, interactive and standardized database of GPCR MD simulations.

Keywords

Beta(2)-adrenergic receptorGuideMetabolomeModels, molecularMolecular dynamics simulationMutagenesisPharmacologyProtein conformationReceptors, g-protein-coupledResidueSimulationsSoftwareTargets

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Nature Methods due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2020, it was in position 1/78, thus managing to position itself as a Q1 (Primer Cuartil), in the category Biochemical Research Methods. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 5.57. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Field Citation Ratio (FCR) from Dimensions: 21.84 (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-07, the following number of citations:

  • WoS: 101
  • Europe PMC: 75

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-07:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 193.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 185 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 75.95.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 98 (Altmetric).
  • The number of mentions in news outlets: 1 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Denmark; Germany; Greece; Italy; Poland; Sweden; Switzerland; United Kingdom; United States of America.